This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Togashi, N. Articles by Shimamoto, K. Search for Related Content PubMed PubMed Citation Articles by Togashi, N. Articles by Shimamoto, K. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB FRUCTOSE GLYCINE Related Collections Growth factors/cytokines Hypertension - basic studies Glucose intolerance

(Hypertension. 2002;39:578.)
© 2002 American Heart Association, Inc.

Scientific Contributions

Effect of TNF-–Converting Enzyme Inhibitor on Insulin Resistance in Fructose-Fed Rats

Nobuhiko Togashi; Nobuyuki Ura; Katsuhiro Higashiura; Hideyuki Murakami; Kazuaki Shimamoto

From the Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Japan

Correspondence to Dr Nobuhiko Togashi, Second Department of Internal Medicine, Sapporo Medical University School of Medicine, S1W16, Chuo-ku, Sapporo 060-8543, Japan. E-mail ntogashi{at}sapmed.ac.jp

Insulin resistance is associated with hypertension, obesity, dyslipidemia, and type 2 diabetes. It is well known that tumor necrosis factor (TNF)- is one of the factors linked to obesity-induced insulin resistance; however, there have been no reports on the role of TNF- in insulin resistance in nonobese insulin-resistant hypertensives. We tested the hypothesis that TNF- affects insulin resistance in nonobese insulin-resistant hypertensive fructose-fed rats (FFR) and that a TNF-–converting enzyme (TACE) inhibitor that blocks TNF- secretion improves insulin resistance in FFR. Six-week-old male Sprague-Dawley rats were fed either standard chow (control) or fructose-rich chow (FFR) for 6 weeks. For the last two weeks of a six-week period of either diet, the rats were treated with a vehicle (control or FFR) or a TACE inhibitor (100 mg/kg/d of KB-R7785; FFR+TACE-I) in peritoneal injection. At the age of 12 weeks, insulin sensitivity was assessed in all conscious rats by the euglycemic hyperinsulinemic glucose clamp technique. While FFR had higher blood pressure than the control rats (P<0.01), the TACE inhibitor did not change blood pressure. Insulin sensitivity (M-value) was reduced in FFR compared with that in the control rats (16.7±1.1 mg/kg per min and 10.3±0.6 mg/kg per min in the control rats and FFR, respectively, P<0.001), and the TACE inhibitor improved insulin sensitivity to the level of the control rats (14.3±1.2 mg/kg per min in FFR+TACE-I, P<0.01). These data indicate that TNF- plays a major role in insulin resistance in nonobese insulin-resistant models and also suggest that TACE would be a good target for controlling insulin resistance not only in obese models but also in nonobese insulin-resistant models.

Key Words: tumor necrosis factor • insulin resistance • fructose • hypertension, essential

This article has been cited by other articles:

				B. LaMarca, J. Speed, L. Fournier, S. A. Babcock, H. Berry, K. Cockrell, and J. P. Granger Hypertension in Response to Chronic Reductions in Uterine Perfusion in Pregnant Rats: Effect of Tumor Necrosis Factor-{alpha} Blockade Hypertension, December 1, 2008; 52(6): 1161 - 1167. [Abstract] [Full Text] [PDF]

				Y. Wei, K. Chen, A. T. Whaley-Connell, C. S. Stump, J. A. Ibdah, and J. R. Sowers Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2008; 294(3): R673 - R680. [Abstract] [Full Text] [PDF]

				M. Serino, R. Menghini, L. Fiorentino, R. Amoruso, A. Mauriello, D. Lauro, P. Sbraccia, M. L. Hribal, R. Lauro, and M. Federici Mice Heterozygous for Tumor Necrosis Factor-{alpha} Converting Enzyme Are Protected From Obesity-Induced Insulin Resistance and Diabetes Diabetes, October 1, 2007; 56(10): 2541 - 2546. [Abstract] [Full Text] [PDF]

				H. Ohtsu, P. J. Dempsey, and S. Eguchi ADAMs as mediators of EGF receptor transactivation by G protein-coupled receptors Am J Physiol Cell Physiol, July 1, 2006; 291(1): C1 - C10. [Abstract] [Full Text] [PDF]

				E. H. Schlenker, Y. Shi, J. Wipf, D. S. Martin, and C. K. Kost Jr. Fructose feeding and intermittent hypoxia affect ventilatory responsiveness to hypoxia and hypercapnia in rats J Appl Physiol, October 1, 2004; 97(4): 1387 - 1394. [Abstract] [Full Text] [PDF]

				T. Shiuchi, M. Iwai, H.-S. Li, L. Wu, L.-J. Min, J.-M. Li, M. Okumura, T.-X. Cui, and M. Horiuchi Angiotensin II Type-1 Receptor Blocker Valsartan Enhances Insulin Sensitivity in Skeletal Muscles of Diabetic Mice Hypertension, May 1, 2004; 43(5): 1003 - 1010. [Abstract] [Full Text] [PDF]

				M. Daly Sugars, insulin sensitivity, and the postprandial state Am. J. Clinical Nutrition, October 1, 2003; 78(4): 865S - 872. [Abstract] [Full Text] [PDF]